Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLCO2B1 | O94956 | 3/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.86 |
| ▸ | KDM1A | O60341 | 2/20 | 0.82 |
| ▸ | PKM | P14618 | 2/20 | 0.79 |
| ▸ | DPP4 | P27487 | 1/20 | 0.76 |
| ▸ | GSK3B | P49841 | 2/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.69 |
| ▸ | UBE2N | P61088 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.64 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.64 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.64 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.64 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.63 |
| ▸ | P4HB | P07237 | 1/20 | 0.63 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20437868 | 1.00 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| SCHEMBL292299 | 1.00 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| SCHEMBL3451231 | 1.00 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| SCHEMBL28281120 | 1.00 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| SCHEMBL29559106 | 1.00 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| Prunin SCHEMBL1122487 | 0.93 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| Prunin SCHEMBL2532187 | 0.93 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| Prunin SCHEMBL31233345 | 0.93 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| Prunin SCHEMBL318230 | 0.93 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM | |
| Prunin SCHEMBL31233342 | 0.93 | SLCO2B1 (1.00) | SLCO2B1SYNJ2PTPN1KDM1APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| CN-120330281-B | Highland barley flavonoid compound glycosyltransferase gene and application thereof | INSTITUTE OF AGRICULTURE, TIBET AUTONOMOUS REGION ACADEMY OF AGRICULTURE AND ANIMAL HUSBANDRY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| US-20240216296-A1 | POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY | EPICEUTICAL LABS LLC | 2024-07-04 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240101791-A1 | POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-28 | — | — | US | disclosed |
| WO-2024059282-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230270148-A1 | BITTER BLOCKERS AND RELATED METHODS OF USE | CONAGEN INC. (US) | 2023-08-31 | — | — | US | disclosed |
| US-9757403-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170246201-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-08-31 | — | — | US | disclosed |
| US-20170151269-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| US-20170151268-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| WO-2017035412-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| US-9492473-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| EP-3071235-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2016122889-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-20160213702-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| WO-2009009906-A1 | ISOFLAVONOID PRODUCTION IN PLANTS | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF AGRICULTURE AND AGRI-FOOD (CA) | 2009-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270148-A1 | BITTER BLOCKERS AND RELATED METHODS OF USE | TAS2R5, TAS2R40, TAS2R30 | SLCO2B1 711/4885SYNJ2 3987/4885PTPN1 2641/4885 |
| US-20240216296-A1 | POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY | FABP2, HDLBP, FABP1 | SLCO2B1 3254/4885SYNJ2 1179/4885PTPN1 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.